Recurrent reactive infectious mucocutaneous eruption in a male adult patient associated with Mycoplasma pneumoniae , SARS-CoV-2 and rhinovirus.

Autor: van Dam V; Dermatology, Algemeen Ziekenhuis Alma campus Eeklo, Eeklo, Belgium vandamvalerie@hotmail.com., Bonny M; Dermatology, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium., Desmet S; Dermatology, Algemeen Ziekenhuis Alma campus Eeklo, Eeklo, Belgium.

Publikováno v: BMJ case reports [BMJ Case Rep] 2023 May 31; Vol. 16 (5). Date of Electronic Publication: 2023 May 31.

Extra-anogenital giant cutaneous squamous cell carcinomas require multidisciplinary management.

Autor: van Dam V; Department of Internal Medicine, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: vandamvalerie@hotmail.com., Trinh XB; Gynaecology Oncology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium., An B; Dermatology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium., Julien L; Dermatology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.

Publikováno v: Cancer treatment and research communications [Cancer Treat Res Commun] 2021; Vol. 28, pp. 100413. Date of Electronic Publication: 2021 Jun 02.

694 - The impact of varicocele on testicular growth during puberty: A cross-sectional observational study

Autor: De Win, G., Van Dam, P.J., Van Dam, V., Van Den Keybus, T., Daems, F., Bauwens, W., Leysen, C., Van Der Heyde, T., Vaganee, D., De Baets, K., Wachter, S.

Publikováno v: In European Urology Supplements March 2018 17(2):e1001-e1001

Transport of peptidoglycan sub-units across the bacterial cytoplasmic membrane

Autor: van Dam, V., Biochemie van Membranen, Biochemistry of membranes, Dep Scheikunde

Transport of peptidoglycan sub-units across the bacterial cytoplasmic membrane Vincent van Dam The work described in this thesis focuses on the mechanism by which the lipid-linked cell wall precursor molecule Lipid II is transported from the inner le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::795f4a964807ba2ca4db595b95489295
https://dspace.library.uu.nl/handle/1874/35139

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

Autor: De Laere B; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. bramdelaere@gmail.com., Oeyen S; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium., Mayrhofer M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Whitington T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., van Dam PJ; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.; HistoGeneX NV, Wilrijk, Antwerp, Belgium., Van Oyen P; Department of Urology, AZ Sint-Jan, Brugge, Belgium., Ghysel C; Department of Urology, AZ Sint-Jan, Brugge, Belgium., Ampe J; Department of Urology, AZ Sint-Jan, Brugge, Belgium., Ost P; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., Demey W; Department of Oncology, AZ KLINA, Brasschaat, Belgium., Hoekx L; Department of Urology, Antwerp University Hospital, Antwerp, Belgium., Schrijvers D; Department of Oncology, ZNA Middelheim, Antwerp, Belgium., Brouwers B; Department of Oncology, AZ Sint-Jan, Brugge, Belgium., Lybaert W; Department of Oncology, AZ Nikolaas, Sint-Niklaas, Belgium., Everaert EG; Department of Oncology, AZ Nikolaas, Sint-Niklaas, Belgium., De Maeseneer D; Department of Oncology, AZ Sint-Lucas, Brugge, Belgium., Strijbos M; Department of Oncology, AZ KLINA, Brasschaat, Belgium., Bols A; Department of Oncology, AZ Sint-Jan, Brugge, Belgium., Fransis K; Department of Urology, Antwerp University Hospital, Antwerp, Belgium., Beije N; Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., de Kruijff IE; Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van Dam V; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium., Brouwer A; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium., Goossens D; Agilent Technologies, Niel, Belgium., Heyrman L; Agilent Technologies, Niel, Belgium., Van den Eynden GG; Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Rutten A; Department of Oncology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Del Favero J; Agilent Technologies, Niel, Belgium., Rantalainen M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Rajan P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Sleijfer S; Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Ullén A; Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Yachnin J; Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Van Laere SJ; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium., Lindberg J; Department of Medical Epidemiology and Biostatistics, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Dirix LY; Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.; Department of Oncology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Mar 15; Vol. 25 (6), pp. 1766-1773. Date of Electronic Publication: 2018 Sep 12.